Beta-blockers modify the prognostic value of adiponectin in chronic heart failure

International Journal of Cardiology

Volumn 150, Issue 3, 2011, Pages 296-300

  Van Berendoncks, An M ^a,b   Beckers, Paul ^a,b   Hoymans, Vicky Y ^a,b   Possemiers, Nadine ^a   Coenen, Samuel ^b   Elseviers, Monique M ^b   Vrints, Christiaan J ^a,b   Conraads, Viviane M ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Adiponectin; Beta blockers; Heart failure; Prognosis

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CLINICAL ASSESSMENT; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC DYSFUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS;

EID: 79960564706     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.04.039     Document Type: Article

References (30)

1. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451 (Pubitemid 40686653)
2. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
3. K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599 (Pubitemid 30353893)
4. M. Adamczak, A. Wiecek, and T. Funahashi Decreased plasma adiponectin concentration in patients with essential hypertension Am J Hypertens 16 2003 72 75 (Pubitemid 36078595)
5. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762 (Pubitemid 41372115)
6. T. Tsutamoto, T. Tanaka, and H. Sakai Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure Eur Heart J 28 2007 1723 1730 (Pubitemid 47227093)
7. J. George, S. Patal, and D. Wexler Circulating adiponectin concentrations in patients with congestive heart failure Heart 92 2006 1420 1424 (Pubitemid 44578832)
8. T. Tamura, Y. Furukawa, and R. Taniguchi Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure Circ J 71 2007 623 630 (Pubitemid 46683348)
9. H. Norrelund, H. Wiggers, and M. Halbirk Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure J Intern Med 260 2006 11 21 (Pubitemid 43894065)
10. M.B. McEntegart, B. Awede, and M.C. Petrie Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 2007 829 835 (Pubitemid 47343601)
11. W.H. Tang, K. Shrestha, and F. Van Lente Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure Am J Cardiol 101 2008 370 373 (Pubitemid 351162964)
12. M.R. Mehra, P.A. Uber, C.J. Lavie, R.V. Milani, M.H. Park, and H.O. Ventura High-density lipoprotein cholesterol levels and prognosis in advanced heart failure J Heart Lung Transplant 28 2009 876 880
13. N. Osada, B.R. Chaitman, and L.W. Miller Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation J Am Coll Cardiol 31 1998 577 582 (Pubitemid 28144124)
14. A.M. Van Berendoncks, P. Beckers, and V.Y. Hoymans Exercise training reduces circulating adiponectin levels in patients with chronic heart failure Clin Sci (Lond) 118 2010 281 289
15. M. von Eynatten, A. Hamann, D. Twardella, P.P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease Clin Chem 52 2006 853 859 (Pubitemid 43673264)
16. C. Sengenes, M. Berlan, I. De Glisezinski, M. Lafontan, and J. Galitzky Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J 14 2000 1345 1351 (Pubitemid 30439743)
17. O. Tsukamoto, M. Fujita, and M. Kato Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure J Am Coll Cardiol 53 2009 2070 2077
18. M. Yamaji, T. Tsutamoto, and T. Tanaka Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus Circ J 73 2009 2264 2269
19. J. Lommi, M. Kupari, and H. Yki-Jarvinen Free fatty acid kinetics and oxidation in congestive heart failure Am J Cardiol 81 1998 45 50 (Pubitemid 28046841)
20. W. Doehner, M. Rauchhaus, and P. Ponikowski Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026 (Pubitemid 41316509)
21. M. Yamaji, T. Tsutamoto, and T. Tanaka Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure Circ J 73 2009 1067 1073
22. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes FEBS Lett 507 2001 142 146 (Pubitemid 33001531)
23. M. Lainscak, I. Keber, and S.D. Anker Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study Int J Cardiol 106 2006 319 322 (Pubitemid 41766632)
24. M. Podbregar, and G. Voga Effect of selective and non-selective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure J Card Fail 8 2002 369 378 (Pubitemid 36055737)
25. D. Herndon, D. Hart, S. Wolf, D. Chinkes, and W. RR Reversal of catabolism by beta-blockade after severe burns N Engl J Med 345 2001 1223 1229 (Pubitemid 34951485)
26. J. Fruebis, T.S. Tsao, and S. Javorschi Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci USA 98 2001 2005 2010 (Pubitemid 32165613)
27. Y. Qi, N. Takahashi, and S.M. Hileman Adiponectin acts in the brain to decrease body weight Nat Med 10 2004 524 529 (Pubitemid 38667912)
28. R. Schnabel, C.M. Messow, and E. Lubos Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
29. K. Kalantar-Zadeh, G. Block, T. Horwich, and G. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444 (Pubitemid 38496352)
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150